Calin
Alternative Names: EMD 66800Latest Information Update: 24 Oct 2021
At a glance
- Originator Biopharm (UK)
- Developer Merck KGaA
- Class Antiplatelets; Invertebrate hormones; Salivary proteins and peptides
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Blood coagulation disorders
Most Recent Events
- 22 Sep 1998 No-Development-Reported for Coagulation disorders (Unknown route)
- 28 Apr 1995 New profile
- 27 Apr 1995 Preclinical development for Coagulation disorders (Unknown route)